treatment of pulmonary tuberculosis. The therapeutic value of collapse therapy has been widely recognised and appreciated.
Thus we are all familiar with the benefits that can be derived from phrenic interruption, artificial pneumothorax, or thoracoplasty with apicolysis, and yet, even with these valuable contributions and many others to collapse therapy, we meet continually the patient for whom very little can be considered in the way of active treatment.
I refer in particular to the case of extensive bilateral pulmonary tuberculosis which is gravely ill, or again, the patient who has a bilateral chest lesion and on whom an artificial pneumothorax has been tried and failed. Their outlook is certainly not I make a practice of telling the patient that some pain will be felt in the above regions, and they are, accordingly, never so worried when they feel the pain. 
